“It’s about my life”: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa
- 3 July 2016
- journal article
- research article
- Published by Taylor & Francis in AIDS Care
- Vol. 29 (7) , 936-942
Abstract
Despite the recent rollout of Isoniazid Preventive Therapy (IPT) to prevent TB in people living with HIV in South Africa, adherence and completion rates are low. To explore barriers to IPT completion in rural KwaZulu-Natal, South Africa, we conducted individual semi-structured interviews among 30 HIV patients who had completed or defaulted IPT. Interview transcripts were analyzed according to the framework method of qualitative analysis. Facilitators of IPT completion included knowledge of TB and IPT, accepting one’s HIV diagnosis, viewing IPT as similar to antiretroviral therapy, having social support in the community and the clinic, trust in the healthcare system, and desire for health preservation. Barriers included misunderstanding of IPT’s preventive role in the absence of symptoms, inefficient health service delivery, ineffective communication with healthcare workers, financial burden of transport to clinic and lost wages, and competing priorities. HIV-related stigma was not identified as a significant barrier to IPT completion, and participants felt confident in their ability to manage stigma, for example by pretending their medications were for unrelated conditions. Completers were more comfortable communicating with health care workers than were defaulters. Efforts to facilitate successful IPT completion must include appropriate counseling and education for individual patients and addressing inefficiencies within the health care system in order to minimize patients’ financial and logistical burden. These patient-level and structural changes are necessary for IPT to successfully reduce TB incidence in this resource-limited setting.Keywords
Funding Information
- Center for Interdisciplinary Research on AIDS (2P30MH062294-11)
- Doris Duke Charitable Foundation
This publication has 18 references indexed in Scilit:
- Preferential adherence to antiretroviral therapy over tuberculosis treatment: A qualitative study of drug-resistant TB/HIV co-infected patients in South AfricaGlobal Public Health, 2014
- Factors Associated with Adherence to Treatment with Isoniazid for the Prevention of Tuberculosis amongst People Living with HIV/AIDS: A Systematic Review of Qualitative DataPLOS ONE, 2014
- A Recent HIV Diagnosis Is Associated with Non-Completion of Isoniazid Preventive Therapy in an HIV-Infected Cohort in Cape TownPLOS ONE, 2012
- Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigationBMC Research Notes, 2012
- Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative studyAIDS, 2010
- Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence settingAIDS, 2010
- Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South AfricaBMC Infectious Diseases, 2006
- Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?2005
- Qualitative research in health care: Analysing qualitative dataBMJ, 2000
- Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, ThailandAIDS, 1997